• Wed, March 31, 2021
• Thu, April 1, 2021
Matthew Luchini Initiated (CCCC) at Buy and Held Target at $55 on, Mar 31st, 2021
Matthew Luchini of BMO Capital, Initiated "C4 Therapeutics, Inc." (CCCC) at Buy and Held Target at $55 on, Mar 31st, 2021.
Matthew, nor any peers, have made any analyst calls on CCCC in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Like: 👍
